Written Question·Department of Health and Social Care·UIN HL15662

Cancer: Medical Treatments

Tabled: 17 March 2026
Answered: 30 March 2026

Question

To ask His Majesty's Government how biomarker testing, as set out in the National Cancer Plan, will be integrated across pathology, genomics services, and multidisciplinary team decision-making to ensure it directly informs treatment selection.

Answer

The National Cancer Plan for England sets out the Government’s commitment to expand and integrate biomarker testing, including blood-based biomarkers known as liquid biopsies and genomic testing, across cancer services to improve treatment selection and o...
ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN HL15662) →